Affiliations
AffiliationsItem in Clipboard
The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 eliminationJason K Gurney et al. Lancet Reg Health West Pac. 2021 May.
doi: 10.1016/j.lanwpc.2021.100127. Epub 2021 Mar 22. Authors Jason K Gurney 1 2 , Elinor Millar 1 , Alex Dunn 1 , Ruth Pirie 1 , Michelle Mako 1 , John Manderson 1 , Claire Hardie 3 , Chris G C A Jackson 4 , Richard North 5 , Myra Ruka 6 , Nina Scott 6 , Diana Sarfati 1 AffiliationsItem in Clipboard
AbstractBackground: The COVID-19 pandemic has disrupted cancer services globally. New Zealand has pursued an elimination strategy to COVID-19, reducing (but not eliminating) this disruption. Early in the pandemic, our national Cancer Control Agency (Te Aho o Te Kahu) began monitoring and reporting on service access to inform national and regional decision-making. In this manuscript we use high-quality, national-level data to describe changes in cancer registrations, diagnosis and treatment over the course of New Zealand's response to COVID-19.
Methods: Data were sourced (2018-2020) from national collections, including cancer registrations, inpatient hospitalisations and outpatient events. Cancer registrations, diagnostic testing (gastrointestinal endoscopy), surgery (colorectal, lung and prostate surgeries), medical oncology access (first specialist appointments [FSAs] and intravenous chemotherapy attendances) and radiation oncology access (FSAs and megavoltage attendances) were extracted. Descriptive analyses of count data were performed, stratified by ethnicity (Indigenous Māori, Pacific Island, non-Māori/non-Pacific).
Findings: Compared to 2018-2019, there was a 40% decline in cancer registrations during New Zealand's national shutdown in March-April 2020, increasing back to pre-shutdown levels over subsequent months. While there was a sharp decline in endoscopies, pre-shutdown volumes were achieved again by August. The impact on cancer surgery and medical oncology has been minimal, but there has been an 8% year-to-date decrease in radiation therapy attendances. With the exception of lung cancer, there is no evidence that existing inequities in service access between ethnic groups have been exacerbated by COVID-19.
Interpretation: The impact of COVID-19 on cancer care in New Zealand has been largely mitigated. The New Zealand experience may provide other agencies or organisations with a sense of the impact of the COVID-19 pandemic on cancer services within a country that has actively pursued elimination of COVID-19.
Funding: Data were provided by New Zealand's Ministry of Health, and analyses completed by Te Aho o Te Kahu staff.
Keywords: COVID; COVID-19; Cancer; Cancer registration; Cancer services; Cancer treatment; Coronavirus.
© 2021 The Authors.
Conflict of interest statementThe authors declare no conflicts of interest.
FiguresFig. 1
Total number of cancer registrations…
Fig. 1
Total number of cancer registrations by month and year (top), alongside the cumulative…
Fig. 1Total number of cancer registrations by month and year (top), alongside the cumulative number of cancer registrations (bottom), for the total population and stratified by ethnicity.
Fig. 2
The number of gastroscopies and…
Fig. 2
The number of gastroscopies and colonoscopies performed over 2020 compared to 2018–2019, by…
Fig. 2The number of gastroscopies and colonoscopies performed over 2020 compared to 2018–2019, by month and year (top) as well as cumulative total (bottom), for the total population and stratified by ethnicity.
Fig. 3
Combined number of prostate, colorectal…
Fig. 3
Combined number of prostate, colorectal and lung surgeries performed over 2020 compared to…
Fig. 3Combined number of prostate, colorectal and lung surgeries performed over 2020 compared to 2018–2019, by month (top) as well as cumulative total (bottom), for the total population and stratified by ethnicity.
Fig. 4
The number of intravenous (IV)…
Fig. 4
The number of intravenous (IV) chemotherapy attendances over 2020 compared to 2018–2019, by…
Fig. 4The number of intravenous (IV) chemotherapy attendances over 2020 compared to 2018–2019, by month (top) as well as cumulative total (bottom), for the total population and stratified by ethnicity.
Fig. 5
The number of radiation therapy…
Fig. 5
The number of radiation therapy attendances over 2020 compared to 2018–2019, by month…
Fig. 5The number of radiation therapy attendances over 2020 compared to 2018–2019, by month (top) as well as cumulative total (bottom), for the total population and stratified by ethnicity.
Similar articlesMillar E, Gurney J, Beuker S, Goza M, Hamilton MA, Hardie C, Jackson CG, Mako M, Middlemiss T, Ruka M, Willis N, Sarfati D. Millar E, et al. Lancet Reg Health West Pac. 2021 Jun 9;11:100172. doi: 10.1016/j.lanwpc.2021.100172. eCollection 2021 Jun. Lancet Reg Health West Pac. 2021. PMID: 34327369 Free PMC article. Review.
Jefferies S, Gilkison C, Duff P, Grey C, French N, Carr H, Priest P, Crengle S. Jefferies S, et al. Public Health. 2025 May 5;244:105732. doi: 10.1016/j.puhe.2025.105732. Online ahead of print. Public Health. 2025. PMID: 40328115
Scott DAR, Hadden PW, Wilson GA. Scott DAR, et al. N Z Med J. 2021 Jul 9;134(1538):120-127. N Z Med J. 2021. PMID: 34239151
Sonder GJ, Grey C, Anglemyer A, Tukuitonga C, Hill PC, Sporle A, Ryan D. Sonder GJ, et al. IJID Reg. 2023 Mar;6:177-183. doi: 10.1016/j.ijregi.2023.01.014. Epub 2023 Feb 1. IJID Reg. 2023. PMID: 36741984 Free PMC article.
Wilson BE, Pokorny AMJ, Perera S, Barton MB, Yip D, Karapetis CS, Ward IG, Downes S, Yap ML. Wilson BE, et al. Asia Pac J Clin Oncol. 2022 Feb;18(1):133-142. doi: 10.1111/ajco.13544. Epub 2021 Feb 25. Asia Pac J Clin Oncol. 2022. PMID: 33629530 Review.
Feier CVI, Bardan R, Muntean C, Olariu A, Olariu S. Feier CVI, et al. Medicina (Kaunas). 2022 Sep 21;58(10):1322. doi: 10.3390/medicina58101322. Medicina (Kaunas). 2022. PMID: 36295483 Free PMC article. Review.
Al-Hussaini M, Al-Ani A, Hammouri M, Al-Huneidy L, Mansour A. Al-Hussaini M, et al. Front Oncol. 2023 Feb 23;13:1088000. doi: 10.3389/fonc.2023.1088000. eCollection 2023. Front Oncol. 2023. PMID: 36910625 Free PMC article.
Eklöv K, Nygren J, Bringman S, Löfgren J, Sjövall A, Nordenvall C, Everhov ÅH. Eklöv K, et al. Colorectal Dis. 2022 Aug;24(8):925-932. doi: 10.1111/codi.16129. Epub 2022 Apr 19. Colorectal Dis. 2022. PMID: 35362199 Free PMC article.
Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Pitz M, Singh H, Thiessen M, Lambert P. Decker KM, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2332363. doi: 10.1001/jamanetworkopen.2023.32363. JAMA Netw Open. 2023. PMID: 37669049 Free PMC article.
Jacob L, Kalder M, Kostev K. Jacob L, et al. J Cancer Res Clin Oncol. 2022 Nov;148(11):3117-3123. doi: 10.1007/s00432-022-03922-5. Epub 2022 Jan 18. J Cancer Res Clin Oncol. 2022. PMID: 35041059 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3